Postdoctoral researcher Cristina Espinosa, senior research assistant Rebecca Ruhl (center) and Dr. Sudarshan Anand in their OHSU lab, November 16, 2016. The early evidence from research by Dr. Sudarshan Anand and his team at OHSU is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Kerri Winters-Stone, Ph.D., F.A.C.S.M., co-director of the OHSU Knight Cancer Institute Community Partnership Program.
(OHSU)

OHSU scientists have found a method to quickly and efficiently map the genome of single cells within the body. Each point in this illustration is a single cell genome sequenced from a pancreatic tumor. The four different colors represent non-cancer cells (green) and three different genetically distinct cancer cell types present within the same tumor. (OHSU)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

Knight Cancer Challenge community celebration at Pioneer Courthouse Square, July 1, 2015. (OHSU)

Michael Heinrich, M.D., professor in the division of hematology and medical oncology at the OHSU Knight Cancer Institute; physician at the Portland Veterans Affairs Medical Center, November 1, 2017. (OHSU/Kristyna Wentz-Graff)

Michael Heinrich, M.D., meets with Todd Bramhall during an exam, November 1, 2017. Bramhall is one of 3,000-6,000 people diagnosed annually with a rare stomach cancer called gastrointestinal stromal tumor (GIST). (OHSU/Kristyna Wentz-Graff)